Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02211534 · ClinicalTrials.gov registry record · NA
Pilot Study of PEMF Therapy in Treatment of Post-operative Pain Following Total Knee Arthroplasty
A NA study of Post-Operative Pain Following Total Knee Arthroplasty, sponsored by Regenesis Biomedical.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 14
- Study locations
NCT02211534: Completed NA study of Post-Operative Pain Following Total Knee Arthroplasty, sponsored by Regenesis Biomedical.
NCT02211534 is a NA study of Post-Operative Pain Following Total Knee Arthroplasty that has completed, run by Regenesis Biomedical. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 14 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02211534, a NA study of Post-Operative Pain Following Total Knee Arthroplasty, has completed, sponsored by Regenesis Biomedical.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 14
- Study locations
Study Summary
The purpose of this study is to investigate whether pulsed electromagnetic energy field (PEMF) therapy is effective in the treatment of persistent pain following total knee arthroplasty (TKA)
Primary Outcome
Percent change from Baseline in Pain Intensity (PI): a validated 11-point Numeric Pain Rating Scale (NPRS) with scores (0-10) collected as patient-reported outcomes on an electronic diary (ePRO). A score of 0 represents 'No Pain' while a score of 10 represents "Worst Pain Imaginable".
Conditions Studied
Interventions
- DEVICE Pulsed Electromagnetic Field Device (Provant)
- DEVICE Sham Pulsed Electromagnetic Field Device
Study Locations (14)
Arizona
- - Phoenix
- - Phoenix
Florida
- - Bradenton
- - Fort Lauderdale
Alabama
- - Birmingham
California
- - El Cajon
Colorado
- - Lone Tree
Nevada
- - Las Vegas
New York
- - New York
North Carolina
- - Raleigh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-03 |
| Phase | NA |
What the finished NCT02211534 record still lists
NCT02211534 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Post-Operative Pain Following Total Knee Arthroplasty appearing as the primary indexed condition, and to 2 interventions - of which Pulsed Electromagnetic Field Device (Provant) is the first listed.
NCT02211534 lists 14 locations in 12 states (Arizona, Florida, Alabama).
Frequently Asked Questions
What is clinical trial NCT02211534 about?
NCT02211534 is a clinical study titled "Pilot Study of PEMF Therapy in Treatment of Post-operative Pain Following Total Knee Arthroplasty". The purpose of this study is to investigate whether pulsed electromagnetic energy field (PEMF) therapy is effective in the treatment of persistent pain following total knee arthroplasty (TKA)
What is the current status of trial NCT02211534?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2014-09. Estimated completion is 2016-03.
What conditions does trial NCT02211534 study?
This clinical trial studies the following conditions: Post-Operative Pain Following Total Knee Arthroplasty.
What interventions are being tested in trial NCT02211534?
The interventions under investigation include: Pulsed Electromagnetic Field Device (Provant) (DEVICE), Sham Pulsed Electromagnetic Field Device (DEVICE).
Who is sponsoring clinical trial NCT02211534?
This trial is sponsored by Regenesis Biomedical, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02211534 being conducted?
This trial has 14 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02211534's enrollment target sits among peer trials
35 1564th of 2000 higher than 431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia